All In MedTech

Device Trial Radar · NCT06449378

Transorb™ Self-Gripping Resorbable Mesh in High-risk Subjects Undergoing Open Repair of Ventral Hernia

Multi-center, Single-arm, Prospective Study of Transorb™ Self-Gripping REsorbable Mesh in High-risk subjeCts Undergoing Open Repair of VEntral heRnia

Last checked: Nov 19, 2026Latest source record: Jul 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

163

Planned (sponsor's estimate)

Start

Jul 2, 2024

Primary completion

Sep 15, 2026

Study completion Oct 1, 2030

Sponsor

Lead sponsor
Medtronic - MITGPublic (MDT)
Sponsor type
Industry
First posted
Jun 10, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of RECOVER is to evaluate the performance and safety of Transorb™ self-gripping resorbable mesh in high-risk subjects (at least one risk factor impairing wound healing) when used for reinforcement of abdominal wall soft tissues in procedures involving open extraperitoneal ventral hernia repair, in clean (US); and clean and clean-contaminated (Europe) surgical fields (Centers for Disease Control and Prevention (CDC) Classification I and II. Data from this study will primarily be used to support market approval and European post-market clinical follow-up needs. Secondarily, data will be used for product marketing, future product development, and to support market release and maintenance in global geographies.

Conditions

  • Hernia
  • Hernia, Ventral
  • Hernia, Abdominal
  • Hernia Abdominal Wall

Interventions

  • Transorb™ Self-Gripping Resorbable MeshDevice

    Self-Gripping Resorbable Mesh used for repair of open ventral hernia.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of clinical hernia recurrenceTime frame: within 12 months

Locations

13 sites in 3 countries. Site status is shown where the registry gives one.

  • Northwestern University

    Evanston, Illinois

  • University of Kentucky

    Lexington, Kentucky

  • Novant Health New Hanover Regional Medical Center

    Wilmington, North Carolina

10 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.